Lee Chan Henry 4
Research Summary
AI-generated summary
BeOne (ONC) SVP/General Counsel Lee Chan Henry Sells 590 Shares
What Happened Lee Chan Henry, SVP and General Counsel of BeOne Medicines (ONC), sold 590 American Depositary Shares (ADS) on June 16, 2026, at $265.98 per ADS for proceeds of $156,925. The filing indicates the sale was effected to satisfy tax withholding obligations related to the vesting of a previously granted restricted share unit (RSU) award — a routine, non-discretionary sale tied to vesting rather than a market-timed equity sale.
Key Details
- Transaction date: 2026-06-16; Filing date (Form 4): 2026-06-18 (filed on time).
- Price and size: 590 ADS at $265.98 each; reported proceeds $156,925.
- ADS conversion: Each ADS represents 13 ordinary shares, so 590 ADS = 7,670 underlying ordinary shares.
- Reason: Sale effected pursuant to mandatory tax withholding on RSU vesting (footnote). Vesting schedule: 1/4 of the award vests each anniversary of June 15, 2023; unvested securities may accelerate on certain termination events.
- Transaction codes: Reported as a sale (S) with tax-withholding treatment per the footnote (F / tax withholding).
- Shares owned after transaction: Not specified in the provided excerpt.
Context This was a tax-withholding sale to cover withholding liabilities when RSUs vested — a common administrative transaction that does not necessarily indicate insider sentiment. For retail investors, purchases by insiders are generally more indicative of conviction; tax-related sales are routine and often required by award agreements.